Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.2K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

266
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
266
Pneumonia IV: Management01:28

Pneumonia IV: Management

359
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

268
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
268
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

336
The pathophysiology of pneumonia involves the following steps:
336
Vaccinations01:51

Vaccinations

44.7K
Overview
44.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Type 2 Diabetes Mellitus Management by an Ambulatory Care Pharmacist vs Usual Care in a Medically Underserved Population.

Journal of pharmacy practice·2026
Same author

Impact of a charitable medication program and social vulnerability index on clinical outcomes in uninsured adults with diabetes.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Improving Pancreatic Function With Elexacaftor/Tezacaftor/Ivacaftor.

Pediatric pulmonology·2026
Same author

One Size May Not Fit All: A Case Series.

Pediatric pulmonology·2026
Same author

Inclusion matters: Describing CF health inequities in American Indian/Alaska Native individuals in Oklahoma.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial.

Arthritis & rheumatology (Hoboken, N.J.)·2024
Same journal

Sleep Worry Among Clinical Nurses: A Cross-Sectional Study.

The American journal of nursing·2026
Same journal

Implementing an Alternative Patient Care Technician Staffing Model on a Medical Unit: A Cross-Sectional Study.

The American journal of nursing·2026
Same journal

In the Gray: What's a Nurse to Do?

The American journal of nursing·2026
Same journal

Enhancing the Professional Work Environment Through Nursing Engagement in an Academic Medical Center.

The American journal of nursing·2026
Same journal

The Nursing the Revolution Exhibit.

The American journal of nursing·2026
Same journal

Code Prep Choreography: Navigating the Urgent Interval.

The American journal of nursing·2026
See all related articles

Related Experiment Video

Updated: Jul 18, 2025

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.7K

Pneumococcal Vaccination in Adults.

Joseph Walter1, Nicole Rudawsky

  • 1Joseph Walter is a clinical assistant professor at the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey in Piscataway, and an ambulatory care pharmacist at JFK Family Medicine Center in Edison, NJ. Nicole Rudawsky is a medical science liaison at AstraZeneca. At the time of this writing, she was a clinical assistant professor at the Ernest Mario School of Pharmacy at Rutgers, and an internal medicine clinical pharmacy specialist at Morristown Medical Center. Contact author: Joseph Walter, joseph.walter@pharmacy.rutgers.edu . The authors have disclosed no potential conflicts of interest, financial or otherwise.

The American Journal of Nursing
|August 24, 2023
PubMed
Summary
This summary is machine-generated.

The Centers for Disease Control and Prevention updated adult pneumococcal vaccine guidelines, introducing PCV15 and PCV20. This review covers recommendations, benefits, drawbacks, and nursing considerations for these new pneumococcal conjugate vaccines.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.5K

Related Experiment Videos

Last Updated: Jul 18, 2025

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.7K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.5K

Area of Science:

  • Public Health
  • Immunology
  • Vaccinology

Background:

  • The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) sets vaccination guidelines.
  • Pneumococcal disease remains a significant public health concern, particularly in adults.
  • Existing pneumococcal vaccines have limitations, necessitating updated recommendations.

Purpose of the Study:

  • To review the updated ACIP recommendations for adult pneumococcal vaccination.
  • To analyze the advantages and disadvantages of the newly recommended pneumococcal conjugate vaccines (PCVs), specifically PCV15 and PCV20.
  • To discuss the implications of these updated guidelines for nursing practice.

Main Methods:

  • Review of the latest ACIP published guidelines on pneumococcal vaccination.
  • Comparative analysis of PCV15 and PCV20 based on available clinical data and efficacy studies.
  • Synthesis of information regarding vaccine safety, immunogenicity, and coverage for different pneumococcal serotypes.

Main Results:

  • Updated recommendations now include PCV15 and PCV20 for adult immunization.
  • PCV15 and PCV20 offer broader serotype coverage compared to previous vaccines.
  • Considerations for vaccine sequencing and patient-specific factors are highlighted.

Conclusions:

  • The introduction of PCV15 and PCV20 represents a significant advancement in preventing pneumococcal disease in adults.
  • Nurses play a crucial role in implementing updated vaccination strategies and educating patients.
  • Adherence to updated guidelines is essential for maximizing vaccine effectiveness and reducing disease burden.